PATENT CLAIM ANALYSIS

Application Number: 16002363
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "064000"]

Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Claim (Index 26):
The compound of any one of  claims 1 - 13 , or pharmaceutically acceptable salts, isomers, stereoisomers, dimers, trimers, tautomers, or N-oxides thereof, wherein R 3  is R 31 ; and R 31  is

Metadata:
- Claim Count in Document: 359.0
- Percentile: 94.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15675253', '15435097', '15162395', '15922376', '14773717']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.796740778459576
- 35 USC 102 Novelty (BERT): 0.5640256450414696
- Combined Prediction Score: 0.7734692651177654
- Mean Citation Score: 406.422242
- Max Citation Score: 442.13254000000006
- Similarity Product: 336.7925836814297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test